Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.

doi:10.1212/wnl.52.2.351

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.

Neurology - 15 Jan 1999

Kastrukoff L F, Morgan N G, Zecchini D, White R, Petkau A J, Satoh J, Paty D W

Abstract excerpt

OBJECTIVE: To determine the effect of treatment with interferon beta-1b (IFN-beta) on natural killer (NK) cell function and phenotype in relapsing-remitting MS (RRMS) patients, and their relationship to disease activity assessed both clinically and with serial MRI. BACKGROUND: NK cells may play a...

Topics

Adjuvants, Immunologic
Adult
Double-Blind Method
Female
Flow Cytometry
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta
Killer Cells, Natural
Magnetic Resonance Imaging
Male
Multiple Sclerosis
Phenotype
Recombinant Proteins
Recurrence
Remission Induction

Source

Open in PubMed

Identifiers

PMID: 9932956
DOI: 10.1212/wnl.52.2.351

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9932956-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics